Siegfried facility in Nantong receives operating approval
Siegfried received operating approval for Phase I of the production plant for active pharmaceutical ingredients at its new facility in Nantong, near Shanghai, China. Validation of the new plant commences with production in the pilot plant. Siegfried plans to produce first commercial batches in the second quarter of 2015.
Walter Kittl, Head Technical Operations at Siegfried: “Operating approval for Nantong represents an important milestone for us. We are convinced that this step will significantly support Siegfried’s growth and further improve our competitiveness.”
Construction of the new production facility in Nantong began mid-2013. It will provide a chemical-pharmaceutical capacity of 350 cubic meters. The technical concept of this facility is similar to that in Zofingen, which will be taken into operation in 2015, and thus - from a regulatory point of view - facilitate product transfer to and from Zofingen.
Once the facility is in full operation, Siegfried will employ some 300 employees in China. At present, 140 employees already work for Siegfried in Nantong.
Other news from the department manufacturing
